US 10588940
Use of angiopoietins in promoting blood coagulation and in the treatment of blood coagulation disorders
granted A61KA61K38/1891A61P
Quick answer
US patent 10588940 (Use of angiopoietins in promoting blood coagulation and in the treatment of blood coagulation disorders) held by REGENERON PHARMACEUTICALS, INC. expires Mon Mar 12 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- REGENERON PHARMACEUTICALS, INC.
- Grant date
- Tue Mar 17 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 12 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 15
- CPC classes
- A61K, A61K38/1891, A61P, A61P7/04